Cyclone Arnab update: Landfall delayed along Andhra Pradesh coast, Odisha to feel impact

Bhubaneswar, Oct. 28 -- Cyclone Arnab's landfall process continued along the Andhra Pradesh coast on Wednesday morning, as the storm moved slowly near the coastline. Its outer bands had entered the la... Read More

US Warns Gulf States to Prepare for Possible New Iran Strikes: WSJ

Afghanistan, Oct. 28 -- The United States has warned several Gulf Arab countries to prepare for a possible "short, intense" military campaign against Iran after the November 3 midterm elections, as Wa... Read More

Emmvee expands manufacturing capacity amid solar-cell supply concerns

New Delhi, Oct. 28 -- Emmvee Photovoltaic Power CMD DV Manjunatha Donthi estimates that India needs around 100 GW of effectively usable solar-cell manufacturing capacity, significantly higher than the... Read More

Heritage's Proposed Yogurt-Unit Merger: Value Addition Requires Distribution Discipline-Khazi Altaf Hussian

India, Oct. 28 -- Heritage Foods' board has approved a proposed amalgamation of its wholly owned subsidiary, Heritage Novandie Foods, with the parent company. The subsidiary manufactures flavoured yo... Read More

Singapore unveils robot to tow fire-hit electric vehicles to safety

Kuala Lampur, Oct. 28 -- Singapore Civil Defence Force unveils robot that can extract, relocate electric vehicles involved in fires SINGAPORE, Oct 28 - With electric vehicles (EV) gaining popularity,... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... Read More

Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... Read More

Singapore Clinical Trial: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Sever... Read More

• ««
• «
• 2513
• 2514
• 2515
• 2516
• 2517
• 2518
• 2519
• 2520
• 2521
• 2522
• »
• »»